HAS2 and neoplasm: Downregulation of HAS2 expression resulted in an inhibition of tumor cell growth and migration as well as an enhancement of cisplatin sensitivity, suggesting the importance of tumor cell HA production to promote in vitro tumor progression behaviors in oral cancer cells [14].